US Broker Ratings

LivaNova PLC (LIVN) Stock Analysis: Exploring a 17% Potential Upside in the Medical Device Sector

LivaNova PLC (NASDAQ: LIVN), a leading player in the medical technology space, is currently garnering significant attention from investors with its promising 17% potential upside. Headquartered in London, United Kingdom,..

Phreesia, Inc. (PHR) Investor Outlook: A 70% Potential Upside in the Healthcare SaaS Space

Phreesia, Inc. (NYSE: PHR) is making waves in the health information services sector with its innovative SaaS-based solutions designed to streamline patient and healthcare provider interactions. With a market capitalization..

BioCryst Pharmaceuticals (BCRX) Stock Analysis: A Rare Disease Innovator with 189% Upside Potential

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) is making waves in the biotechnology sector, primarily due to its focus on developing treatments for rare diseases. With a market capitalization of $1.49 billion,..

Janux Therapeutics, Inc. (JANX) Stock Analysis: A High-Stakes Bet with 358% Potential Upside

For investors seeking high-growth opportunities in the biotechnology sector, Janux Therapeutics, Inc. (NASDAQ: JANX) presents an intriguing proposition. A clinical-stage biopharmaceutical company, Janux is at the forefront of developing innovative..

Certara, Inc. (CERT) Stock Analysis: A Healthcare Innovator with 31.79% Potential Upside

Certara, Inc. (CERT) is making waves in the healthcare sector with its innovative approach to biosimulation and model-informed drug development. Based in Radnor, Pennsylvania, Certara provides a suite of technology-enabled..

Astrana Health Inc. (ASTH) Stock Analysis: Significant Revenue Growth and a Promising 26% Upside

Astrana Health Inc. (NASDAQ: ASTH), a prominent player in the healthcare sector, is making waves with its robust revenue growth and substantial potential upside. With a market capitalization of $1.47..

Kestra Medical Technologies (KMTS) Stock Analysis: Exploring a 25.71% Upside Potential in the Healthcare Sector

Kestra Medical Technologies, Ltd. (NASDAQ: KMTS) is capturing investor attention in the healthcare arena, particularly within the Medical Instruments & Supplies industry. With a market cap standing at $1.37 billion,..

Harrow, Inc. (HROW) Stock Analysis: A 47.63% Potential Upside in the Healthcare Sector

Harrow, Inc. (HROW), a distinguished player in the healthcare sector, particularly within the niche of specialty and generic drug manufacturing, has been capturing investor attention with its recent financial and..

Brookdale Senior Living Inc. (BKD) Stock Analysis: Evaluating Its 18.67% Potential Upside

Brookdale Senior Living Inc. (NYSE: BKD), a prominent player in the healthcare sector, specifically within the medical care facilities industry, has been drawing attention due to its strategic positioning in..

PACS Group, Inc. (PACS) Stock Analysis: Healthcare Player with a 6.48% Upside and Strong Buy Ratings

PACS Group, Inc. (PACS), a prominent player in the healthcare sector, specifically in the medical care facilities industry, has captured the attention of investors with its robust growth metrics and..

MiMedx Group, Inc (MDXG) Stock Analysis: A Biotech Gem with 96.67% Upside Potential

MiMedx Group, Inc. (NASDAQ: MDXG) stands out in the biotechnology sector, not just for its innovative approach to healthcare but also for its appealing investment potential. With a market capitalization..

10x Genomics, Inc. (TXG) Stock Analysis: A Closer Look at Valuation Challenges Amidst Sector Potential

For investors navigating the dynamic landscape of health information services, 10x Genomics, Inc. (NASDAQ: TXG) presents a compelling case study. With its innovative platforms designed to revolutionize biological analysis, 10x..

Viridian Therapeutics, Inc. (VRDN): Growth Potential in Biotechnology with an 81,958% Revenue Surge

Viridian Therapeutics, Inc. (NASDAQ: VRDN), a promising player in the biotechnology sector, is capturing the attention of investors with its impressive revenue growth and a robust pipeline of treatments for..

LeMaitre Vascular (LMAT) Stock Analysis: Exploring a 23.66% Upside in the Healthcare Sector

For investors eyeing opportunities within the healthcare sector, LeMaitre Vascular, Inc. (NASDAQ: LMAT) presents a compelling case. Headquartered in Burlington, Massachusetts, LeMaitre specializes in medical instruments and supplies, specifically targeting..

Beam Therapeutics Inc. (BEAM): An Investor’s Insight into Its 34% Upside Potential and Strategic Collaborations

Beam Therapeutics Inc. (NASDAQ: BEAM), a pioneer in precision genetic medicines, is capturing the attention of investors with its innovative approach to treating serious diseases. Based in Cambridge, Massachusetts, this..

Amphastar Pharmaceuticals, Inc. (AMPH): Investor Outlook with a 7.39% Upside Potential

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a prominent player in the healthcare sector, focuses on the development and commercialization of generic and proprietary pharmaceuticals. Headquartered in Rancho Cucamonga, California, Amphastar operates..

BioLife Solutions, Inc. (BLFS) Stock Analysis: Exploring a 34.78% Potential Upside in the Booming Cell and Gene Therapy Market

BioLife Solutions, Inc. (NASDAQ: BLFS) represents a compelling opportunity in the healthcare sector, particularly within the rapidly expanding field of cell and gene therapy (CGT). Headquartered in Bothell, Washington, BioLife..

Dyne Therapeutics, Inc. (DYN)

⚠️ No article content returned.

..

Omnicell, Inc. (OMCL) Stock Analysis: Unlocking a 5.49% Upside in the Healthcare Tech Space

Omnicell, Inc. (NASDAQ: OMCL) is capturing the attention of investors with its compelling growth story and strategic position in the healthcare technology sector. With a market capitalization of $2.35 billion,..

Arrowhead Pharmaceuticals (ARWR) Stock Analysis: A Biotech Gem with 17% Upside Potential

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR), a prominent player in the biotechnology industry, is capturing investor attention with its innovative approach to tackling intractable diseases. The Pasadena, California-based company is making..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds